APG Asset Management
RPRX icon

APG Asset Management’s Royalty Pharma RPRX Stock Holding History

APG Asset Management’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.1M Sell
227,127
-34,148
-13% -$1.78M 0.03% 369
2026
Q1 		$10.9M Sell
261,275
-29,789
-10% -$1.3M 0.03% 327
2025
Q4 		$9.58M Sell
291,064
-22,578
-7% -$861K 0.03% 361
2025
Q3 		$9.42M Sell
313,642
-12,192
-4% -$441K 0.03% 361
2025
Q2 		$10M Buy
325,834
+7,842
+2% +$260K 0.03% 364
2025
Q1 		$9.16M Sell
317,992
-64,914
-17% -$2.06M 0.03% 375
2024
Q4 		$9.43M Buy
382,906
+17,406
+5% +$462K 0.03% 379
2024
Q3 		$9.26M Sell
365,500
-326,770
-47% -$9.05M 0.06% 205
2024
Q2 		$17M Buy
692,270
+298,986
+76% +$8.29M 0.03% 346
2024
Q1 		$11.1M Buy
393,284
+120,164
+44% +$3.54M 0.02% 406
2023
Q4 		$6.95M Sell
273,120
-17,667
-6% -$486K 0.01% 448
2023
Q3 		$7.89M Sell
290,787
-34,524
-11% -$1.03M 0.02% 436
2023
Q2 		$9.17M Buy
325,311
+9,661
+3% +$327K 0.02% 421
2023
Q1 		$10.5M Sell
315,650
-49,332
-14% -$1.83M 0.02% 413
2022
Q4 		$14.4M Buy
364,982
+273,408
+299% +$11.4M 0.03% 407
2022
Q3 		$3.76M Buy
91,574
+47,869
+110% +$2.04M 0.01% 470
2022
Q2 		$1.76M Buy
43,705
+29,038
+198% +$1.19M ﹤0.01% 568
2022
Q1 		$514K Buy
14,667
+3,017
+26% +$118K ﹤0.01% 803
2021
Q4 		$408K Sell
11,650
-309
-3% -$12K ﹤0.01% 876
2021
Q3 		$373K Sell
11,959
-3,352
-22% -$130K ﹤0.01% 879
2021
Q2 		$529K Buy
15,311
+654
+4% +$27.8K ﹤0.01% 867
2021
Q1 		$544K Buy
+14,657
New +$695K ﹤0.01% 892

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

APG Asset Management's RPRX Position: Q2 2026 in Review

APG Asset Management reduced its Royalty Pharma (RPRX) stake by 13% in Q2 2026, selling an estimated $1.78M and leaving 227,127 shares worth $11.1M. The position accounts for 0.03% of the portfolio, ranked #369.

APG Asset Management first reported a position in RPRX in Q1 2021 and has held it in 22 quarters since. The position peaked at $17M in Q2 2024. 502 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • APG Asset Management held 227,127 shares of Royalty Pharma worth $11.1M as of Q2 2026.
  • APG Asset Management sold 34,148 Royalty Pharma shares in Q2 2026, an estimated $1.78M.
  • Royalty Pharma made up 0.03% of APG Asset Management's portfolio in Q2 2026, its #369 holding.
  • APG Asset Management first reported a position in Royalty Pharma in Q1 2021 and has held it in 22 quarters since.
  • APG Asset Management's Royalty Pharma position peaked at $17M in Q2 2024.
  • 502 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on APG Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.